Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1979 3
1980 2
1982 2
1983 1
1989 1
1993 3
2004 1
2007 2
2009 2
2010 1
2013 1
2018 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Insulin Resistance in HIV-Patients: Causes and Consequences.
Pedro MN, Rocha GZ, Guadagnini D, Santos A, Magro DO, Assalin HB, Oliveira AG, Pedro RJ, Saad MJA. Pedro MN, et al. Front Endocrinol (Lausanne). 2018 Sep 5;9:514. doi: 10.3389/fendo.2018.00514. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30233499 Free PMC article. Review.
Safety and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced patients: 24-week results of POWER 3.
Molina JM, Cohen C, Katlama C, Grinsztejn B, Timerman A, Pedro Rde J, Vangeneugden T, Miralles D, Meyer SD, Parys W, Lefebvre E; TMC114-C208 Study Group; TMC114-C215 Study Group. Molina JM, et al. Among authors: pedro rde j. J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):24-31. doi: 10.1097/QAI.0b013e3181359cfb. J Acquir Immune Defic Syndr. 2007. PMID: 17621237 Clinical Trial.
Safety and immunovirologic outcomes with maraviroc combination regimens in patients with a history of past treatment failures and virologic resistance in Brazil: an open-label, multicenter phase 3b study.
Furtado J, Madruga JV, Bicudo EL, da Eira M, Lopes MI, Netto EM, Santini-Oliveira M, Leite OH, Machado AA, Tupinambas U, de Andrade Neto JL, Lima MP, Pedro Rde J, Miranda AF, Lewi DS, Santos BR, Portsmouth S, Wajsbrot DB, Cassoli LM. Furtado J, et al. Among authors: pedro rde j. AIDS Res Hum Retroviruses. 2013 Sep;29(9):1203-10. doi: 10.1089/AID.2012.0330. Epub 2013 Jun 25. AIDS Res Hum Retroviruses. 2013. PMID: 23731330 Clinical Trial.
[Paracoccidioidomycosis and infection by the human immunodeficiency virus].
Pedro Rde J, Aoki FH, Boccato RS, Branchiní ML, Gonçales Júnior FL, Papaiordanou PM, Ramos Mde C. Pedro Rde J, et al. Rev Inst Med Trop Sao Paulo. 1989 Mar-Apr;31(2):119-25. doi: 10.1590/s0036-46651989000200010. Rev Inst Med Trop Sao Paulo. 1989. PMID: 2690307 Portuguese.
Epidermolysis bullosa hereditaria letalis.
Waldrigues A, Pedro Rde J, Grossi C. Waldrigues A, et al. Among authors: pedro rde j. Lancet. 1972 Dec 23;2(7791):1372. doi: 10.1016/s0140-6736(72)92822-x. Lancet. 1972. PMID: 4118243 No abstract available.
22 results